Geron

GERN

GERN
Geron Stock Quote
$1.69 $0.01 0.6%
Price as of September 25, 2020, 4:30 p.m. EDT View Interactive GERN Charts

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

Interactive Chart


News & Analysis: Geron

The Fool has written over 300 articles on Geron.

All

Market Moves

Podcasts

Earnings



Why Geron Stock Soared 23.4% Today

The bio pharmaceutical announced fresh data on imetelstat that it will present at a key conference next month.






Better Buy: Geron vs. Incyte

Formed in the early ‘90s, Geron and Incyte exemplify the long and often tumultuous road it takes to translate science into medicines.